时隔十余年，拥有184年历史的零售巨头屈臣氏集团再度启动上市计划。据资本市场消息，其母公司长江和记实业拟于2026年上半年推动屈臣氏在香港与英 国两地双重上市，计划募资20亿美元（约合142亿元人民币），若进程顺利，屈臣氏估值有望突破300亿美元。 这场看似雄心勃勃的资本布局，实则是长江和记千亿债务承压与屈臣氏中国市场持续遇挫的双重困境下，一场"以优质资产换流动性"的战略突围。 资金压力下的资本求助？ 屈臣氏的上市计划并非临时起意，而是酝酿十余年的第三次尝试。早在2013年底，集团就曾披露港英双重上市意向，当时估值一度超过3000亿港币，最终因 2014年港股低迷及舆论风波搁置。 如今屈臣氏重启上市进程，表面上是趁着2025年港股IPO市场回暖、六部委支持消费企业上市的政策窗口期进行冲刺。 知名战略定位专家、福建华策品牌定位咨询创始人詹军豪则表示："一方面，港股回暖与政策支持提供了良好窗口期，20亿美元募资可缓解母公司债务压 力，增强财务灵活性，同时通过双地上市分散地缘政治风险，构建东西方资本平衡。" 实际上，在屈臣氏冲刺IPO的背后，其母公司正面临着资金压力以及自身业务的双重承压。 从母公司长江和记的财务状 ...

Group 1 - The core point of the article is that CK Hutchison Holdings is planning a dual listing for its subsidiary, Watsons Group, in Hong Kong and the UK in the first half of 2026, aiming to raise approximately $2 billion (about HKD 15.5 billion) [1][2] - If the IPO process goes smoothly, Watsons Group's valuation is expected to exceed $30 billion, making it one of the largest consumer retail IPOs in Hong Kong in recent years [1] - Watsons Group, founded in 1841 in Hong Kong, is a well-known international health and beauty retail group and has been a core retail business of CK Hutchison since its acquisition in 1981 [1][2] Group 2 - According to CK Hutchison's financial report for the first half of 2025, Watsons contributed total retail revenue of HKD 98.84 billion, a year-on-year increase of 8%, with EBITDA reaching HKD 7.974 billion, up 12% [2] - The total number of global stores reached 16,935, and the number of loyal members surpassed 175 million, with exclusive product sales accounting for 36% of total sales [2] - However, Watsons' business in China faced challenges, with total revenue declining by 3% and a net reduction of 145 stores, alongside a 1.0% decrease in same-store sales [2]

Group 1 - CK Hutchison Holdings Limited (referred to as "CK Hutchison") is considering the spin-off of its Watsons Group, with plans for dual listings in Hong Kong and the UK, aiming to raise up to $2 billion (approximately RMB 14.215 billion) [1] - The IPO plan for Watsons was previously delayed due to the pandemic and a downturn in investor sentiment, but with the recent recovery in the global IPO market, the spin-off is back on the agenda, potentially starting in the first half of 2026 [1] - The listing plan for Watsons is still in the preliminary evaluation stage, with no final decisions made regarding the specific issuance scale and timeline [1] Group 2 - CK Hutchison's retail segment, which includes Watsons Group, reported total revenue of HKD 98.84 billion (approximately RMB 90.271 billion) for the first half of 2025, representing an 8% year-on-year increase [2] - Despite strong global performance, revenue in China totaled HKD 6.666 billion (approximately RMB 6.088 billion), reflecting a year-on-year decline of 3.1% [2] - The announcement indicated that the health and beauty product business in China will continue to face challenges in the second half of the year [2]

Core Viewpoint - CK Hutchison Holdings (0001.HK) is considering a dual listing for its subsidiary, Watsons Group, in Hong Kong and the UK, with an IPO planned for the first half of next year [1]. Group 1: Company Background - Watsons, founded in 1841, is a historic health and beauty retail group acquired by Li Ka-shing in 1981 [4]. - In 2014, CK Hutchison sold 24.95% of Watsons Group to Singapore's Temasek for HKD 44 billion, making Temasek the second-largest shareholder [4]. Group 2: Financial Performance - CK Hutchison's retail business, which includes Watsons, reported a revenue increase of 4% to HKD 190.19 billion for 2024, with EBITDA rising 1% to HKD 16.395 billion [5]. - However, the Chinese market for health and beauty products saw an 18% revenue decline, while other Asian markets grew by 6% and European markets by 8% [5]. - EBITDA for the Chinese market dropped by 55%, negatively impacting overall profitability in Asia, while Europe saw a 9% increase [5]. Group 3: Market Challenges - The Chinese market is the only region where Watsons experienced declines in revenue, profitability, and store count, with a 3% revenue drop and a 53% EBITDA decline in the first half of 2025 [7]. - As of June 30, 2025, the total number of retail stores globally increased by 2% to 16,935, but the number of stores in China decreased by 4% to 3,630 [7]. - CK Hutchison indicated that the health and beauty business in China will continue to face challenges in the second half of the year, prompting Watsons to enhance its value positioning and optimize store locations [7].

Core Viewpoint - Watsons is accelerating its transformation in response to fierce competition from e-commerce platforms and the rise of new beauty retail formats, seeking a "revival strategy" [2] Management Changes - On November 1, 2023, Pan Meiling will succeed Li Jiale as the Managing Director of Hong Kong Watsons, with Li continuing as a business advisor until December 2025 [3] - The new appointee, Pan Meiling, has over 20 years of experience in the fast-moving consumer goods and retail sectors, and is expected to leverage her market knowledge to drive team performance [3] - The Hong Kong Retail CEO, Qu Wenhui, who took office in March 2023, aims to enhance customer experience across over 500 O+O (offline and online) stores in Hong Kong [3] Digital Transformation and O+O Strategy - The term "O+O" has been frequently mentioned in the context of Watsons' digital transformation, which aims to seamlessly integrate offline and online platforms to enhance consumer shopping experiences [5] - Watsons is focusing on digital channels and platforms to establish closer communication with consumers, utilizing its store network and service teams [5] Financial Performance - In the first half of 2025, Watsons' retail division reported total revenue of HKD 98.84 billion, an 8% year-on-year increase, with the health and beauty segment contributing HKD 87.86 billion, accounting for 89% of total revenue [6][9] - The health and beauty segment saw a 4.5% year-on-year increase in same-store sales, while EBITDA and EBIT improved, driven by strong performance in European and Asian markets, although the Chinese market showed weakness with a slight decline of 1% in same-store sales [7] - From 2022 to 2024, Watsons' health and beauty business in China experienced revenue declines of 23%, 6%, and 18%, respectively, with a 15.3% drop in same-store sales in 2024 [8] Store Operations - As of June 30, 2025, Watsons had 3,630 stores in China, down from 3,775 the previous year, reflecting a net closure of 145 stores due to the decision to close underperforming locations [11] - The company is expanding its "back-end stores," which serve as small order fulfillment centers for online orders, increasing from 131 to 394 stores in the first half of the year [11]

Core Viewpoint - Watsons Group, under Li Ka-shing, is continuously reducing its store count in China, reflecting a strategic shift in response to declining performance in the region [2][4]. Financial Performance - In the first half of 2025, Watsons Group reported a revenue of HKD 6.666 billion in China, a year-on-year decrease of 3% [2][3]. - The EBITDA for the same period was HKD 117 million, down 53% compared to the previous year [2][3]. Store Count and Sales Performance - The number of stores in China decreased by 145, representing a 4% reduction year-on-year [4][6]. - The year-on-year sales growth rate for stores in China improved from -18.6% to -1% [4][5]. Strategic Adjustments - The reduction in store count is part of a strategy to optimize the store portfolio, closing underperforming locations upon lease expiration [6]. - The company is increasing its online fulfillment capabilities, with the number of micro-fulfillment centers rising from 131 to 394 [6]. Regional Performance - Other regions, such as Asia and Europe, are performing well, with significant growth in sales and store counts, contrasting sharply with the decline in China [3][5]. - In Asia, store count increased by 796, with a sales growth rate of 6.4% [5]. Employment Trends - The number of employees in Chengdu Watsons has decreased from 1,582 in 2022 to 1,204 in 2024, indicating a trend of workforce reduction [8]. - Similarly, in Chongqing, employee numbers have also shown a continuous decline from 600 in 2022 to 501 in 2024 [10]. Overall Strategy - The company is adopting a dual strategy of closing inefficient physical stores while expanding its online and warehousing capabilities to enhance competitive advantage amid pressures from e-commerce and local beauty stores [11].

Core Viewpoint - The company has achieved a gross margin of 75% and generates over 100 million in annual revenue from selling health and beauty products in Hong Kong, indicating strong market potential as it prepares for an IPO [1] Group 1 - The company specializes in health and beauty products, which have shown significant demand in the Hong Kong market [1] - The impressive gross margin of 75% highlights the company's effective cost management and pricing strategy [1] - Annual revenue exceeding 100 million demonstrates the company's established market presence and financial stability [1] Group 2 - The upcoming IPO reflects the company's growth ambitions and the potential for attracting further investment [1] - The health and beauty industry in Hong Kong is characterized by robust consumer spending, providing a favorable environment for the company's expansion [1] - The company's strong financial performance positions it well to capitalize on market opportunities post-IPO [1]